These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 8058069)
21. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. Ohba M; Shibanuma M; Kuroki T; Nose K J Cell Biol; 1994 Aug; 126(4):1079-88. PubMed ID: 8051207 [TBL] [Abstract][Full Text] [Related]
22. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein. Madden SL; Cook DM; Rauscher FJ Oncogene; 1993 Jul; 8(7):1713-20. PubMed ID: 8510918 [TBL] [Abstract][Full Text] [Related]
23. Regulation of nov by WT1: a potential role for nov in nephrogenesis. Martinerie C; Chevalier G; Rauscher FJ; Perbal B Oncogene; 1996 Apr; 12(7):1479-92. PubMed ID: 8622864 [TBL] [Abstract][Full Text] [Related]
24. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065 [TBL] [Abstract][Full Text] [Related]
25. A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1. Wang ZY; Qiu QQ; Enger KT; Deuel TF Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8896-900. PubMed ID: 8415628 [TBL] [Abstract][Full Text] [Related]
26. High affinity binding sites for the Wilms' tumour suppressor protein WT1. Hamilton TB; Barilla KC; Romaniuk PJ Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533 [TBL] [Abstract][Full Text] [Related]
27. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666 [TBL] [Abstract][Full Text] [Related]
28. WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Wang ZY; Qiu QQ; Gurrieri M; Huang J; Deuel TF Oncogene; 1995 Mar; 10(6):1243-7. PubMed ID: 7700651 [TBL] [Abstract][Full Text] [Related]
29. Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box. Tatarowicz WA; Martin CE; Pekosz AS; Madden SL; Rauscher FJ; Chiang SY; Beerman TA; Fraser NW J Neurovirol; 1997 Jun; 3(3):212-24. PubMed ID: 9200069 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Morris JF; Madden SL; Tournay OE; Cook DM; Sukhatme VP; Rauscher FJ Oncogene; 1991 Dec; 6(12):2339-48. PubMed ID: 1662794 [TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta 1 responsiveness of the rat osteocalcin gene is mediated by an activator protein-1 binding site. Banerjee C; Stein JL; Van Wijnen AJ; Frenkel B; Lian JB; Stein GS Endocrinology; 1996 May; 137(5):1991-2000. PubMed ID: 8612540 [TBL] [Abstract][Full Text] [Related]
32. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285 [TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
34. Involvement of serum response element in okadaic acid-induced EGR-1 transcription in human T-cells. Chauhan D; Kharbanda SM; Uchiyama H; Sukhatme VP; Kufe DW; Anderson KC Cancer Res; 1994 Apr; 54(8):2234-9. PubMed ID: 8174132 [TBL] [Abstract][Full Text] [Related]
35. Sp1 is a critical regulator of the Wilms' tumor-1 gene. Cohen HT; Bossone SA; Zhu G; McDonald GA; Sukhatme VP J Biol Chem; 1997 Jan; 272(5):2901-13. PubMed ID: 9006935 [TBL] [Abstract][Full Text] [Related]
36. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. Moshier JA; Skunca M; Wu W; Boppana SM; Rauscher FJ; Dosescu J Nucleic Acids Res; 1996 Mar; 24(6):1149-57. PubMed ID: 8604351 [TBL] [Abstract][Full Text] [Related]
37. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Nakagama H; Heinrich G; Pelletier J; Housman DE Mol Cell Biol; 1995 Mar; 15(3):1489-98. PubMed ID: 7862142 [TBL] [Abstract][Full Text] [Related]
38. The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site. Yoo YD; Chiou CJ; Choi KS; Yi Y; Michelson S; Kim S; Hayward GS; Kim SJ J Virol; 1996 Oct; 70(10):7062-70. PubMed ID: 8794351 [TBL] [Abstract][Full Text] [Related]
39. Induction of epidermal growth factor receptor gene transcription by transforming growth factor beta 1: association with loss of protein binding to a negative regulatory element. Hou X; Johnson AC; Rosner MR Cell Growth Differ; 1994 Aug; 5(8):801-9. PubMed ID: 7986746 [TBL] [Abstract][Full Text] [Related]
40. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors. Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]